ArticlePDF Available

Psycho-Emotional Factors Associated with Depressive Symptoms during Lockdown Due to the COVID-19 Pandemic in the Mexican Population

MDPI
International Journal of Environmental Research and Public Health (IJERPH)
Authors:

Abstract and Figures

The COVID-19 pandemic has had a significant impact on mental health, leading to the increase of depressive symptoms. Identifying these symptoms and the factors associated with them in women and men will allow us to understand possible mechanisms of action and develop more specific interventions. An online survey was conducted from 1 May to 30 June 2020 using snowball sampling; the final sample comprised 4122 adult inhabitants of Mexico; 35% of the total sample displayed moderate-to-severe depressive symptoms, with a greater proportion of depression being among female respondents. A logistic regression analysis revealed that individuals under 30 years of age, those with high levels of stress due to social distancing, those with negative emotions, and those who reported a significant impact of the pandemic on their lives have a higher risk of depression. Women with a history of mental health treatment and men with a history of chronic disease were also more likely to experience depressive symptoms. Social environment and sex are factors that intervene in the development of depressive symptoms, meaning that appropriate early identification and intervention models should be designed for the care of men and women in highly disruptive situations such as the recent pandemic.
Content may be subject to copyright.
Citation: Martínez-Vélez, N.A.;
Arroyo-Belmonte, M.; Tiburcio, M.;
Natera-Rey, G.; Fernández-Torres, M.;
Sánchez-Hernández, G.Y. Psycho-
Emotional Factors Associated with
Depressive Symptoms during
Lockdown Due to the COVID-19
Pandemic in the Mexican Population.
Int. J. Environ. Res. Public Health 2023,
20, 4331. https://doi.org/10.3390/
ijerph20054331
Academic Editor: Jie Zhang
Received: 1 February 2023
Revised: 23 February 2023
Accepted: 24 February 2023
Published: 28 February 2023
Copyright: © 2023 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
International Journal of
Environmental Research
and Public Health
Article
Psycho-Emotional Factors Associated with Depressive
Symptoms during Lockdown Due to the COVID-19
Pandemic in the Mexican Population
Nora A. Martínez-Vélez, Miriam Arroyo-Belmonte, Marcela Tiburcio *, Guillermina Natera-Rey, Morise Fernández-Torres
and Graciela Y. Sánchez-Hernández
Department of Social Sciences in Health, Direction of Epidemiological and Psychosocial Research,
Ramón de la Fuente Muñiz National Institute of Psychiatry, Calzada Mexico-Xochimilco 101,
San Lorenzo Huipulco, Tlalpan, Mexico City 14370, Mexico
*Correspondence: tibsam@imp.edu.mx; Tel.: +52-55-4160-5162
Abstract:
The COVID-19 pandemic has had a significant impact on mental health, leading to the
increase of depressive symptoms. Identifying these symptoms and the factors associated with them
in women and men will allow us to understand possible mechanisms of action and develop more
specific interventions. An online survey was conducted from 1 May to 30 June 2020 using snowball
sampling; the final sample comprised 4122 adult inhabitants of Mexico; 35% of the total sample
displayed moderate-to-severe depressive symptoms, with a greater proportion of depression being
among female respondents. A logistic regression analysis revealed that individuals under 30 years of
age, those with high levels of stress due to social distancing, those with negative emotions, and those
who reported a significant impact of the pandemic on their lives have a higher risk of depression.
Women with a history of mental health treatment and men with a history of chronic disease were
also more likely to experience depressive symptoms. Social environment and sex are factors that
intervene in the development of depressive symptoms, meaning that appropriate early identification
and intervention models should be designed for the care of men and women in highly disruptive
situations such as the recent pandemic.
Keywords: mental health; depressive symptomatology; COVID-19
1. Introduction
The public health emergency caused by COVID-19 began in December 2019, with the
first cases in Mexico being identified in February 2020 and the declaration of a national
emergency in the country at the end of March 2020 [
1
]. This emergency posed complex
challenges for the general population as, in addition to the obvious consequences for
physical health, it affected the mental health of men and women [
2
]. Much of the literature
published to date has identified an increase in moderate or severe symptoms of acute
stress, anxiety, and depression [
3
9
]. Since the start of the pandemic, there has been a
worldwide increase of 27.6% in depressive disorders, with women and young people being
the most affected [
10
]. Mexico has been no exception: an online survey of medical students
conducted from April to December 2020 found that the prevalence of depressive symptoms
increased during that period from 19.84% to 40.8% [11].
Few studies, however, have analyzed the factors behind this increase. Stress is well-
known as a trigger of depressive reactions, fear, and anxiety [
12
16
]. Stressors related to
previous natural disasters and accidents have been linked to declines in mental health not
just during these events, but for many months or years after the events [17,18].
The stress generation model of depression (SGMD) [
19
,
20
] has substantially con-
tributed to an advanced understanding of the relationship between stress and depression
and of the factors and mechanisms involved in its persistence and recurrence; it allows us
Int. J. Environ. Res. Public Health 2023,20, 4331. https://doi.org/10.3390/ijerph20054331 https://www.mdpi.com/journal/ijerph
Int. J. Environ. Res. Public Health 2023,20, 4331 2 of 10
to understand that not all domains of stressful life events have an equal effect on people’s
health. This model differentiates the impact of factors associated with the discord in peo-
ple’s interpersonal relationships and the factors of their context (such as financial stress,
academic or work difficulties, and poor health) in the shaping of depression [
12
,
19
,
20
].
The COVID-19 pandemic affected interpersonal relationships through restrictions on so-
cial interactions [
21
], and it has also generated contextual changes such as disruptions in
employment, personal finances, and work–life balance [22,23].
However, we do not know if these factors have affected women and men equally or if
they have had a differentiated impact on this increase in depression. Studies carried out
at the start of the pandemic have found that being female, younger (particularly under
35 years of age), and having less education or financial resources were variables that were
associated with the presence of depressive symptoms [
9
,
16
,
24
]. Other studies, however,
suggest that various factors have been associated with a higher risk of depression during
the COVID-19 pandemic. Early in the pandemic, pre-existing mental health conditions,
living alone, and marital status were associated with elevated levels of anxiety and/or de-
pression [
25
]. Physical health conditions, being in close contact with people with
COVID-19
,
mental comorbidity, coping styles, stigmas, psychosocial support, personal protection mea-
sures, risk of contracting COVID-19, and concerns that a family member would be infected
were also associated with depression [2,26].
In addition to these contextual stress factors, psycho-emotional factors also play a
fundamental role in the configuration of depressive symptomatology. A pandemic triggers
an emotional response [
27
] that can range from risk denial to high levels of fear and
anxiety [
28
]. Some studies have suggested that women tend to be more worried, anxious,
scared, sad, and angry than men [
29
,
30
]. The SGMD has also recognized the important
role of emotion as an associated factor, which is usually conceptualized in broad categories
such as negative versus positive emotions [
31
]. For example, it has been observed that
positive affect may facilitate resilience in the presence of stressors and reduce vulnerability
to mental health disorders [32].
Although there is evidence of differences between women and men in the stress and
worry experienced during the pandemic, the contextual and psycho-emotional correlates
that imply a greater risk of developing depressive symptoms have not been accurately
identified. The purpose of this article, therefore, is to estimate the prevalence of depressive
symptoms and to identify the influence of psycho-emotional and contextual stress factors
associated with the COVID-19 pandemic on depressive symptoms in men and women in
the early months of the pandemic lockdown. We expected to find similar results to those
reported in previous research conducted, where the impact on women’s mental health is
more severe than on men.
2. Materials and Methods
This was an exploratory descriptive study, and data was collected using an online
survey; the main objective of the study was to explore substance use and the presence of
mental health problems during the lockdown due to the COVID-19 pandemic.
The online survey was conducted using Google Forms in May and June of 2020, the pe-
riod in which Mexico experienced the strictest lockdown. The link to the questionnaire was
published on the official social media accounts (Facebook, (Zuckerberg, Saverin, McCollum,
Moskovitz & Hughes, 2004, Cambridge, MA, USA), Twitter, (Dorsey, Williams, Glass &
Stone, 2006, San Francisco, CA, USA) and WhatsApp (Acton, Koum, WhatsApp LLC, Menlo
Park, CA, USA; Meta Platforms, Inc. version 2.21.15.20, 2009, Cambridge, MA, USA)) of the
Ramón de la Fuente Muñiz National Institute of Psychiatry. A total of 4122 individuals were
surveyed. All of them were aged 18 years or over, were residents of Mexico, and provided
consent for their voluntary participation [
33
]. The questionnaire comprised 13 sections;
however, we have only reported on the following:
Ten questions about sex, age, educational attainment, marital status, occupation, state
of origin, income, and family characteristics.
Int. J. Environ. Res. Public Health 2023,20, 4331 3 of 10
Adversity and Stress Scale: Eleven questions formulated for this study were used to
measure the stress level caused by the pandemic in different aspects of life during the
previous month. The questions were divided into two groups: (a) relational stress, derived
from the effects on social interactions at school or work or on the management of free
time (six items); and (b) contextual stress, associated with changes in a person’s social and
economic status (five items). There were five response options on a Likert scale ranging
from 0 (“not at all or only slightly stressful”) to 4 (“very stressful”). The evaluation of
the scale’s psychometric characteristics yielded a reliability coefficient of 0.86 for this
sample [34].
Patient Health Questionnaire-2 (PHQ-2): This questionnaire included the first two
questions from the PHQ-9, which identified depressive symptomatology in the previous
two weeks. There were four response options ranging from 0 (“never”) to 3 (“almost
every day”) with a maximum possible score of 6 [
35
]. In Mexico, the discriminating power
of this questionnaire has been evaluated with indigenous women, and the best cutoff
point found was 3, with a sensitivity of 80% and a specificity of 86.8% [
36
]. The reliability
coefficient for this sample was 0.78. In the meta-analysis by Levis et al. [
37
], the cut-off
point of
3 has a 72% sensitivity and 85% specificity independent of the respondent’s sex.
Perceived threat and experiences with coronavirus: This was a short version of three scales
developed by Conway, Woodard, and Zubrod [
38
] that explore the perceived threat of the
coronavirus (three items,
α
= 0.89: “Thinking about the coronavirus [COVID-19] makes me
feel threatened”, “I am afraid of the coronavirus [COVID-19]”, and “I am stressed around
other people because I worry I’ll catch the coronavirus [COVID-19]”), the impact of the
coronavirus (six items,
α
= 0.84: “The coronavirus [COVID-19] has impacted me negatively
from a financial point of view”, “I have lost job-related income due to the coronavirus
[COVID-19]”, “I have had a hard time getting needed resources (food, toilet paper) due
to the coronavirus [COVID-19]”, “It has been difficult for me to get the things I need due
to the coronavirus [COVID-19]”, “I have become depressed because of the coronavirus
[COVID-19]”, and “the coronavirus (COVID-19) outbreak has impacted my psychological
health negatively”), and experiences with coronavirus (seven items,
α
= 0.71: “I have been
diagnosed with the coronavirus [COVID-19]”, “I have had coronavirus-like symptoms
at some point in the past two months”, “I have been sick from something other than the
coronavirus in the past two months”, “I have been in close proximity with someone who
has been diagnosed with coronavirus [COVID-19]”, “I have been in close proximity with
someone who has had coronavirus-like symptoms in the last two months”, “I watch a lot of
news about the coronavirus [COVID-19]”, and “I spend a huge percentage of my time trying
to find updates online or on TV about coronavirus [COVID-19]”). The scales, translated
into Spanish for this study, contain seven Likert responses ranging from 1 (“not true of me
at all”) to 7 (“very true of me”) [33].
Emotional state: This questionnaire was created for the study; it is a list of 12 feelings,
consisting of six positive (happiness, hope, pleasantness, joy, relaxation, tranquility) and
six negative (boredom, stress, fear, vulnerability, worry, despair) emotions that could be
experienced during the lockdown.
Descriptive statistics were used to determine the sociodemographic characteristics
of the respondents. The mean score and dimensions of the scales and the prevalence of
depressive symptomatology (PHQ-2 score
3) were obtained. X
2
and Student’s t-tests
were performed to evaluate the differences by sex. The effect size was measured with
Cramer’s V coefficient for X
2
tests and Cohen’s d for t-tests. Binomial logistic regression
models were used to identify the factors associated with depressive symptomatology in
men and women. Th adjusted odds ratios (OR) are reported with 95% confidence intervals
(CI). The Hosmer–Lemeshow test was used to assess the fit of the models. All statistical
analyses were performed using the Statistical Package for the Social Sciences (SPSS) for
Windows (version 25.0, IBM Corp., Armonk, NY, USA).
Int. J. Environ. Res. Public Health 2023,20, 4331 4 of 10
3. Results
3.1. Respondent Characteristics
A total of 4122 responses were obtained. Only 28.2% of the respondents were men;
the majority of respondents were aged 21–40 years (55.9%), were unpartnered (57.1%), had
completed undergraduate and postgraduate studies (77.2%), and were employed (69.1%)
(for more details about the survey, see Martínez-Vélez et al. [33]).
As can be seen in Table 1, significant differences were found between men and women
in the psychosocial factors associated with the pandemic. More women than men reported
having previously been in treatment for mental health (29.9% vs. 21.9%) together with
a higher percentage of depressive symptoms (38.2% vs. 28.1%) and higher stress scores
in interpersonal interactions. Likewise, women reported experiencing negative feelings
more often than men and felt more threatened from the coronavirus. Conversely, men
reported a greater number of previous chronic diseases than women (34.7% vs. 22.1%) and
higher scores on the context-related stress (family economy, family health, socio-economic
status); men also reported experiencing more positive feelings with statistically significant
differences in relation to women.
Table 1. Percentage distribution of the psychosocial factors associated with the pandemic by sex.
Men Women Total
(n = 1160) (n = 2962) (n = 4122)
f%f%f%X2/df p V *
Previous chronic illness
No 757 65.3 2051 69.2 2808 68.1 6.096/1 0.014 0.038
Yes 403 34.7 911 30.8 1314 31.9
Tx mental health in the past 12 months
No 906 78.1 2076 70.1 2982 72.3 26.768/1 0.000 0.081
Yes 254 21.9 886 29.9 1140 27.7
Depressive symptomatology
PHQ2 2 834 71.9 1831 61.8 2665 64.7 37.062/1 0.000 0.095
PHQ2 3 326 28.1 1131 38.2 1457 35.3
Mean SD Mean SD Mean SD t/df p d **
Relational stress 1.08 0.90 1.30 0.92 1.24 0.92 6.95/4120 0.000 0.245
Contextual stress 1.44 1.02 1.73 1.04 1.63 1.05 8.16/4120 0.000 0.285
Positive emotions during lockdown 17.52 5.58 16.92 5.27 17.08 5.36 3.15/4120 0.001 0.107
Negative emotions during lockdown 16.77 6.46 19.58 6.30 18.79 6.47 12.79/4120 0.000 0.435
Impact of coronavirus 15.97 8.68 16.22 8.65 16.15 8.66 0.84/4120 0.401 0.029
Experiences of coronavirus 14.97 7.35 14.75 7.22 14.81 7.25 0.87/4120 0.386 0.029
Threat of coronavirus 8.63 5.11 9.97 5.61 9.59 5.50 7.32/4120 0.000 0.261
* Cramer’s V; ** Cohen’s d.
3.2. Depressive Symptoms
The respondents with depressive symptoms were mostly women, aged 21–30 years,
single, and with bachelor’s degrees. People who reported having been in treatment for
a mental health problem in the previous 12 months showed the highest percentages of
depressive symptoms, and this difference was statically significant; however, the effect size
of this difference was low. On the other hand, the lowest scores of depressive symptoms
were reported among the group of respondents aged 31–40 years. The highest levels of
stress, negative emotions or feelings, impact of coronavirus, experiences with the virus, and
feeling threatened by COVID-19 were reported by people with three or more symptoms of
depression (Table 2).
Int. J. Environ. Res. Public Health 2023,20, 4331 5 of 10
Table 2.
Percentage distribution of the demographic data and psychosocial factors associated with
the pandemic due to depressive symptomatology.
Without Depressive
Symptomatology
(PHQ2 2)
With Depressive
Symptomatology
(PHQ2 3)
(n = 2665) (n = 1457)
f%f%X2/df p V *
Sex
Male 834 31.3 326 22.4 37.062/1 0.000 0.095
Female 1831 68.7 1131 77.6
Age
18–20 years 143 5.4 180 12.4 239.444/4 0.000 0.241
21–30 years 609 22.9 549 37.7
31–40 years 765 28.7 380 26.1
41–50 years 600 22.5 218 15.0
51 years or over 548 20.6 130 8.9
Marital Status
Single 1102 41.4 828 56.8 92.644/3 0.000 0.150
Married/partnered 1274 47.8 496 34.0
Divorced/separated 252 9.5 118 8.1
Widowed 37 1.4 15 1.0
Education
Elementary/Jr. High 75 2.8 49 3.4 26.799/3 0.000 0.117
High School 450 16.9 367 25.2
Bachelor’s Degree 1413 53.0 756 51.9
Graduate Degree 727 27.3 285 19.6
Occupation
Homemaker 129 4.8 75 5.1 175.391/5 0.000 0.206
Unemployed b/l 81 3.0 89 6.1
Unemployed s/l 105 3.9 97 6.7
Employed 1608 60.3 639 43.9
Student 332 12.5 366 25.1
Self-employed 410 15.4 191 13.1
Previous chronic illness
No 1819 68.3 989 67.9 0.061/1 0.807 0.004
Yes 846 31.7 468 32.1
Mental health Tx in the past 12 months
No 2103 78.9 879 60.3 162.575/1 0.000 0.199
Yes 562 21.1 578 39.7
Mean SD Mean SD t/df p d **
Pandemic-related stress
Relational stress 0.89 0.74 1.87 0.88 37.826/4120 0.000 1.323
Contextual stress 1.32 0.92 2.24 1.00 29.534/4120 0.000 0.990
Positive emotions during lockdown 18.38 5.23 14.72 4.76 22.143/4120 0.000 0.699
Negative emotions during lockdown 16.38 5.78 23.21 5.24 37.462/4120 0.000 1.181
Impact of coronavirus 13.73 7.45 20.57 8.97 26.149/4120 0.000 0.980
Experiences of coronavirus 13.54 6.54 17.13 7.90 15.590/4120 0.000 0.547
Threat of coronavirus 8.47 4.99 11.65 5.80 18.434/4120 0.000 0.636
* Cramer´sV; ** Cohen’s d.
3.3. Identification of Factors Associated with Depressive Symptoms in Women and Men
The factors associated with depressive symptoms during the COVID-19 lockdown are
shown in Table 3. The logistic regression model for men showed that those aged 18–20 years
(OR = 2.74, 95% CI [1.33, 5.64]), and those aged 21–30 years (OR = 1.7, 95% CI [1.03, 9.96])
were more likely to present with depressive symptoms than those aged 51 years or over.
Those who had a previous history of chronic disease were more likely to have symptoms
(OR = 0.69, 95% CI [0.47, 1.48]) than those who did not. Furthermore, those who reported
more stress associated with interpersonal relationships (OR = 1.8, 95% CI [1.44, 2.42]), more
negative emotions (OR = 1.1, 95% CI [1.13, 1.22]), those experiencing a greater impact of
COVID-19 (OR = 1.0, 95% CI [1.01, 1.05]), those with a greater degree of experience of
the pandemic (OR = 1.0, 95% CI [1.01, 1.05]), and those with a greater perceived threat
from COVID-19 (OR = 0.929, 95% CI [0.981–0.969]) were more likely to present depressive
symptoms than those who reported lower levels of these factors.
Int. J. Environ. Res. Public Health 2023,20, 4331 6 of 10
Table 3. Factors associated with the depressive symptomatology during lockdown by sex.
Risk of Depressive Symptomatology
Men * Women **
(n = 1160) (n = 2962)
OR pOR p
Social vulnerability
Age
51 years or over 1 - 1
18–20 years 2.74 0.01 4.62 0.00
21–30 years 1.72 0.05 1.90 0.00
31–40 years 0.96 0.89 1.37 0.07
41–50 years 0.82 0.52 1.12 0.52
Psychobiological vulnerability
Previous chronic illness
No 1 - 1 -
Yes 0.63 0.01 0.91 0.37
Tx mental health disorder in the past 12 months
No 1 - 1 -
Yes 0.69 0.06 0.77 0.01
Impact of COVID pandemic
Pandemic-related stress
Relational stress 1.87 0.00 1.64 0.00
Contextual stress 0.95 0.657 1.10 0.18
Positive emotions during lockdown 0.94 0.00 0.87 0.00
Negative emotions during lockdown 1.17 0.00 1.15 0.00
Impact of coronavirus 1.04 0.00 1.03 0.00
Experiences due to coronavirus 1.03 0.02 1.00 0.68
Threat of coronavirus 0.93 0.00 0.98 0.08
* Logistic regression model in men (
χ2
= 460.26, gl = 13, p< 0.001); Hosmer–Lemeshow test (
χ2
= 9.61, gl = 8,
p= 0.294). The model explained between 33% Cox & Snell and 47% Negelkerke of the variance. The total correct
prediction was 81%, and it included 57% of those who had depressive symptoms and 91% of those who did not.
** Logistic regression model in women (
χ2
= 1296.24, gl = 13, p< 0.001); Hosmer–Lemeshow test (
χ2
= 21.53, gl = 8,
p= 0.06). The model explained between 35% Cox & Snell and 48% Negelkerke of the variance. The total correct
prediction was 80%, and it included 70% of those who had depressive symptoms and 86% of those who did not.
Younger women were also more likely to present depressive symptoms than women
over 51 years old. Having been in mental health treatment in the past 12 months increased
the risk of presenting depressive symptoms (OR = 0.77, 95% CI [0.63, 0.95]). Those who
reported more stress associated with interpersonal relationships (OR = 1.6, 95% CI [1.40, 1.89]),
more negative emotions (OR = 1.1, 95% CI [1.12, 1.17]), and those with a greater impact
of the coronavirus (OR = 1.0, 95% CI [1.02, 1.05]) were more likely to present depressive
symptoms than those who reported lower levels of these factors.
4. Discussion
This study estimated the prevalence of depressive symptoms and their contextual and
psycho-emotional correlates among Mexican women and men during the early months
of the COVID-19 pandemic lockdown. It was found that 38% of women and 28% of men
presented depressive symptoms. The prevalence of these symptoms was much higher
than that reported in previous studies in Mexico, which has ranged between 12% and
25% depending on the study population [
36
,
39
]; furthermore, it was much higher than the
prevalence of major depressive disorder in Mexico, which is estimated to be present in
7.2% of the general population [
40
]. A similar prevalence of depressive symptoms has been
identified as a result of the pandemic in countries such as China and Spain with a greater
proportion being found in women than in men [7,8].
Our results suggest that the COVID-19 pandemic has substantially affected the mental
health of men and women in Mexico, and these findings are consistent with previous
Int. J. Environ. Res. Public Health 2023,20, 4331 7 of 10
studies that reported that exposure to public health emergencies, such as in the case of
the Ebola and SARS outbreaks, can cause mental health problems [
41
,
42
]. Global evidence
supports the observation of this upward trend in depression symptoms due to emotional
distress and stressors related to COVID-19, including the disruption of social relationships,
isolation, fears of illness and economic loss, and concern for one’s own health and that
of loved ones, all of which can trigger depression or exacerbate existing symptoms [
21
].
The survey showed high percentages of people who reported that they feared that their
mental health would be affected by COVID-19 (between 87% and 92%). There was also a
high level of negative emotions experienced during lockdown together with significant
stress levels associated with the pandemic.
This high prevalence of stress and negative emotions, especially regarding relation-
ships, was significantly linked to the presence of depressive symptoms for both sexes.
These findings coincide with the stress generation model of depression (SGMD), which
has documented that both interpersonal and non-interpersonal stress are well-established
risk factors for major depressive disorder, with interpersonal stress having the greatest
impact [
12
,
19
,
20
]. It has also been observed that positive emotions significantly reduce
the effects of interpersonal stress on the severity of depressive symptoms, while negative
emotions increase the effects of non-interpersonal stress on their severity [32].
For both men and women, the stressful effect of the COVID-19 pandemic lockdown on
areas of life such as personal relationships and the changes in context or life situations led to
a situation of continuous tension from different sources, including the economic status and
health of the family, which resulted in an increased risk for depressive symptoms [4345].
While the predictors of depressive symptomatology were similar between men and
women, there were some differences between the two groups. In general, women tend
to experience negative emotions more intensely than men, which can make them more
susceptible to depression. The review study of Bracke et al. [
46
] points to the association
between gender inequality and depression, showing that gender differences in depression
converge in contexts of greater gender equality and increase in contexts of greater inequality.
These effects compound the consequences for the mental health of taking on work and
family functions at different stages of life. The SGMD also allows us to understand how
gender can shape depression. For example, there is evidence that stress linked to interper-
sonal relationships can be greater for women, in part because of the greater emphasis such
relationships have in women’s lives, especially those characterized by caring for others and
emotional closeness [47].
On the other hand, in the case of men, having a pre-existing physical illness and
experiencing direct encounters with COVID-19 (experiences of coronavirus) were more
associated with depressive symptoms than in women. Rutland-Lawes et al. [
48
] also
identified that a long-standing illness, together with other factors such as alcohol use,
living alone/not alone, and employment status were all significant predictors of change
in depression scores in men. In this sense, we can hypothesize that the loss of health
or functionality and the risk of getting sick could be important predictors of depressive
symptoms in men.
The findings of this study allow for a better, timely understanding of the psychological
consequences of contingencies such as the COVID-19 pandemic, which is essential for
several reasons. First, there is a high prevalence of psychological problems among those
directly or indirectly exposed to potentially stressful situations. Such problems can affect
the daily functioning of a substantial number of people and can cause immediate social and
economic consequences, such as the loss of productivity at work and financial difficulties.
Strategies for protecting the psychological health of men and women through mental health
interventions are crucial for preventing or offsetting interruptions in the delivery of health
services during emergencies.
There is an important need for a greater focus on and understanding of the effect of
the environment on depressive disorders in men and women, which is better understood
through solid frameworks and hypothetical constructs such as the SGMD. Empirical find-
Int. J. Environ. Res. Public Health 2023,20, 4331 8 of 10
ings and new perspectives can greatly contribute to our understanding of these phenomena
and also to the construction of interventions promoting mental health that are sensitive to
differences in gender at times of great stress, such as in the recent pandemic.
Limitations. This study has certain limitations. First, its cross-sectional design means
that causality cannot be inferred from the results. Second, since the population was under
lockdown, the data were collected online through convenience sampling, and the results are
therefore not generalizable to the entire population. Third, the answers were self-reported,
which may have led to information biases. Finally, the lack of evidence about the validity of
the PHQ-2 survey for assessing depressive symptoms among Mexican males is a limitation
of our study, although some studies [
37
] do not make distinctions by gender regarding its
sensibility and specificity. Therefore, the results should be taken with caution.
5. Conclusions
The findings of this study provide information on the structure and correlates of stress
associated with the COVID-19 pandemic and their influence on the presence of depressive
symptoms; they add to the knowledge on how socioenvironmental risk influences mental
health [
49
]. The results also shed light on the nature and degree of psychological responses
to the pandemic and have the potential to serve as a basis for the development of health
promotion and prevention strategies which, together with existing efforts, have the potential to
contain the burden of mental illness. The study shows that strategies that promote the mental
health of the population should be encouraged to prepare for this type of contingency.
Author Contributions:
Conceptualization, M.T., G.N.-R., N.A.M.-V., M.A.-B., G.Y.S.-H. and M.F.-T.
formal analysis, M.A.-B. and N.A.M.-V.; investigation, M.T., G.N.-R., N.A.M.-V., M.A.-B., G.Y.S.-H.
and M.F.-T.; data curation, N.A.M.-V. and M.A.-B.; writing—original draft preparation, N.A.M.-V.
and M.A.-B.; writing—review and editing, M.T., N.A.M.-V. and M.A.-B. All authors have read and
agreed to the published version of the manuscript.
Funding: This research received no external funding.
Institutional Review Board Statement:
The research protocol and data collection for this study were
approved by the Ethics Committee of the Ramón de la Fuente Muñiz National Institute of Psychiatry
(Approval No. CEI/C/011/2020).
Informed Consent Statement: Informed consent was obtained from all subjects involved in the study.
Data Availability Statement: Not available.
Acknowledgments:
The authors are grateful to the Ramón de La Fuente Muñiz National Institute of
Psychiatry for all of the facilities provided.
Conflicts of Interest: The authors declare that they have no conflict of interest.
References
1.
Secretaría de Salud. Casos Confirmados a Enfermedad por COVID-19. Comunicado Técnico Diario. Available online:
https://www.gob.mx/salud/documentos/coronavirus-covid-19-comunicado-tecnico-diario-238449 (accessed on 30 May 2020).
2.
Hossain, M.M.; Tasnim, S.; Sultana, A.; Faizah, F.; Mazumder, H.; Zou, L.; Lizako, E.; McKyer, J.; Ahmed, H.U.; Ma, P.
Epidemiology of mental health problems in COVID-19: A review. F1000Research 2020,9, 2–16. [CrossRef] [PubMed]
3.
Ahorsu, D.K.; Lin, C.Y.; Imani, V.; Saffari, M.; Griffiths, M.D.; Pakpour, A.H. The fear of COVID-19 scale: Development and initial
validation. Int. J. Ment. Health Addict. 2020,20, 1537–1545. [CrossRef] [PubMed]
4.
Li, S.; Wang, Y.; Xue, J.; Zhao, N.; Zhu, T. The impact of COVID-19 epidemic declaration on psychological consequences: A study
on active Weibo users. Int. J. Environ. Res. Public Health 2020,17, 2032. [CrossRef] [PubMed]
5.
Qiu, J.; Shen, B.; Zhao, M.; Wang, Z.; Xie, B.; Xu, Y. A nationwide survey of psychological distress among Chinese people in the
COVID-19 epidemic: Implications and policy recommendations. Gen. Psychiatry 2020,33, e100213. [CrossRef]
6.
Roy, D.; Tripathy, S.; Kar, S.K.; Sharma, N.; Verma, S.K.; Kaushal, V. Study of knowledge, attitude, anxiety & perceived mental
healthcare need in Indian population during COVID-19 pandemic. Asian J. Psychiatry 2020,51, 102083. [CrossRef]
7.
Rodríguez, R.; Garrido, H.; Collado, S. Psychological impact and associated factors during the initial stage of the coronavirus
(COVID-19) pandemic among the general population in Spain. Front. Psychol. 2020,11, 1540. [CrossRef]
Int. J. Environ. Res. Public Health 2023,20, 4331 9 of 10
8.
Wang, C.; Pan, R.; Wan, X.; Tan, Y.; Xu, L.; Ho, C.S.; Ho, R.C. Immediate psychological responses and associated factors during
the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int. J. Environ. Res.
Public Health 2020,17, 1729. [CrossRef]
9.
Xiong, J.; Lipsitz, O.; Nasri, F.; Lui, L.M.; Gill, H.; Phan, L.; Chen-Li, D.; Iacobucci, M.; Ho, R.; Majeed, A.; et al. Impact
of COVID-19 pandemic on mental health in the general population: A systematic review. J. Affect. Disord.
2020
,277, 55–64.
[CrossRef]
10. COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries
and territories in 2020 due to the COVID-19 pandemic. Lancet 2021,398, 1700–1712. [CrossRef]
11.
Domínguez, A.D.; Guzmán, G.; Ángeles, F.S.; Manjarrez, M.A.; Secín, R. Depression and suicidal ideation in Mexican medical
students during COVID-19 outbreak. A longitudinal study. Heliyon 2022,8, e08851. [CrossRef]
12.
Connolly, N.P.; Eberhart, N.K.; Hammen, C.L.; Brennan, P.A. Specifi city of stress generation: A comparison of adolescents with
depressive, anxiety, and comorbid diagnoses. J. Cogn. Ther. 2010,3, 368–379. [CrossRef] [PubMed]
13.
Gotlib, I.H.; Joormann, J. Cognition and depression: Current status and future directions. Annu. Rev. Clin. Psychol.
2010
,6,
285–312. [CrossRef] [PubMed]
14.
Hammen, C. Depression and stressful environments: Identifying gaps in conceptualization and measurement. Anxiety Stress Coping
2016,29, 335–351. [CrossRef] [PubMed]
15.
Kendler, K.S.; Gardner, C.O. Depressive vulnerability, stressful life events and episode onset of major depression: A longitudinal
model. Psychol. Med. 2016,46, 1865–1874. [CrossRef]
16. Shader, R.I. COVID-19 and Depression. Clin. Ther. 2020,42, 962–963. [CrossRef]
17. Goldmann, E.; Galea, S. Mental health consequences of disasters. Annu. Rev. Public Health 2014,35, 169–183. [CrossRef]
18.
Norris, F.H.; Friedman, M.J.; Watson, P.J.; Byrne, C.M.; Diaz, E.; Kaniasty, K. 60,000 disaster victims speak: Part I. An empirical
review of the empirical literature, 1981—2001. Psychiatry 2002,65, 207–239. [CrossRef]
19. Hammen, C. Generation of stress in the course of unipolar depression. J. Abnorm. Soc. Psychol. 1991,100, 555–561. [CrossRef]
20.
Hammen, C. Stress generation in depression: Reflections on origins, research, and future directions. J. Clin. Psychol.
2006
,62,
1065–1082. [CrossRef]
21.
Skałacka, K.; Pajestka, G. Digital or In-Person: The Relationship Between Mode of Interpersonal Communication During the
COVID-19 Pandemic and Mental Health in Older Adults From 27 Countries. J. Fam. Nurs. 2021,27, 275–284. [CrossRef]
22.
Kwong, A.S.; Pearson, R.M.; Adams, M.J.; Northstone, K.; Tilling, K.; Smith, D.; Fawns-Ritchie, C.; Bould, H.; Ware, N.; Zammit, S.;
et al. Mental health before and during the COVID-19 pandemic in two longitudinal UK population cohorts. Br. J. Psychiatry
2021
,
218, 334–343. [CrossRef] [PubMed]
23.
Ettman, C.K.; Abdalla, S.M.; Cohen, G.H.; Sampson, L.; Vivier, P.M.; Galea, S. Prevalence of depression symptoms in US adults
before and during the COVID-19 pandemic. JAMA Netw. Open 2020,3, e2019686. [CrossRef] [PubMed]
24. Stanton, R.; To, Q.G.; Khalesi, S.; Williams, S.L.; Alley, S.J.; Thwaite, T.L.; Fenning, A.; Vandelanotte, C. Depression, anxiety, and
stress during COVID-19: Associations with changes in physical activity, sleep, tobacco, and alcohol use in Australian adults.
Int. J. Environ. Res. Public Health 2020,17, 4065. [CrossRef] [PubMed]
25.
Özdin, S.; Bayrak Özdin, ¸S. Levels and predictors of anxiety, depression and health anxiety during COVID-19 pandemic in
Turkish society: The importance of gender. Int. J. Soc. Psychiatry 2020,66, 504–511. [CrossRef] [PubMed]
26.
Toledo, A.; Betancourt, D.; Romo, H.; Reyes, E.; González, A. A cross-sectional survey of psychological distress in a Mexican
sample during the second phase of the COVID-19 pandemic. OSF Prepr. 2020. [CrossRef]
27.
Taylor, S. The Psychology of Pandemics: Preparing for the Next Global Outbreak of Infectious Disease; Cambridge Scholars Publishing:
Newcastle upon Tyne, UK, 2019.
28.
Wheaton, M.G.; Abramowitz, J.S.; Berman, N.C.; Fabricant, L.E.; Olatunji, B.O. Psychological predictors of anxiety in response to
the H1N1 (swine flu) pandemic. Cognit. Ther. Res. 2012,36, 210–218. [CrossRef]
29.
Van der Vegt, I.; Kleinberg, B. Women Worry about Family, Men about the Economy: Gender Differences in Emotional Responses
to COVID-19; Aref, S., Bontcheva, K., Braghieri, M., Dignum, F., Giannotti, F., Grisolia, F., Pedreschi, D., Eds.; Social Informatics.
SocInfo 2020. Lecture Notes in Computer Science; Springer: Cham, Switzerland, 2020; Volume 12467. [CrossRef]
30.
Ramos-Lira, L.; Rafull, C.; Flores-Celis, K.; Mora, J.; García-Andrade, C.; Rascón-Gasca, M.L.; Bautista, A.; Cervantes, C.
Emotional responses and coping strategies in adult Mexican population during the first lockdown of the COVID-19 pandemic:
An exploratory study by sex. Salud Ment. 2020,43, 243–251. [CrossRef]
31. Levenson, R.W. Stress and illness: A role for specific emotions. Psychosom. Med. 2019,81, 720–730. [CrossRef]
32.
Sewart, A.R.; Zbozinek, T.D.; Hammen, C.; Zinbarg, R.E.; Mineka, S.; Craske, M.G. Positive affect as a buffer between chronic
stress and symptom severity of emotional disorders. Clin. Psychol. Sci. 2019,7, 914–927. [CrossRef]
33.
Martínez-Vélez, N.A.; Tiburcio, M.; Natera, G.; Villatoro Velázquez, J.A.; Arroyo-Belmonte, M.; Sánchez, G.Y.; Torres, M.
Psychoactive substance use and its relationship to stress, emotional state, depressive symptomatology, and perceived threat
during the COVID-19 pandemic in Mexico. Front. Public Health 2021,9, 709410. [CrossRef]
34.
Arroyo-Belmonte, M.; Natera, G.; Tiburcio, M.; Martínez-Vélez, N.A. Development and psychometric properties of the adversity
and stress scale (ASS): Validation in the adult mexican population. Int. J. Ment. Health Addict. 2021, 1–15. [CrossRef] [PubMed]
35.
Kroenke, K.; Spitzer, R.L.; Williams, J.B. The patient health questionnaire-2: Validity of a two-item depression screener. Med. Care
2003,41, 1284–1292. [CrossRef] [PubMed]
Int. J. Environ. Res. Public Health 2023,20, 4331 10 of 10
36.
Arrieta, J.; Aguerrebere, M.; Raviola, G.; Flores, H.; Elliott, P.; Espinosa, A.; Reyes, A.; Ortiz-Panozo, E.; Rodriguez, E.G.;
Mulkherjee, J.; et al. Validity and utility of the Patient Health Questionnaire (PHQ)-2 and PHQ-9 for screening and diagnosis of
depression in rural Chiapas, Mexico: A cross-sectional study. J. Clin. Psychol. 2017,73, 1076–1090. [CrossRef] [PubMed]
37.
Levis, B.; Sun, Y.; He, C.; Wu, Y.; Krishnan, A.; Mani, P.; Neupane, D.; Imran, M.; Brehaut, E.; Negeri, Z.; et al. Accuracy
of the PHQ-2 Alone and in Combination With the PHQ-9 for Screening to Detect Major Depression: Systematic Review and
Meta-analysis. JAMA 2020,323, 2290–2300. [CrossRef] [PubMed]
38.
Conway, L.; Woodard, S.; Zubrod, A.; Tiburcio, M.; Martínez-Vélez, N.A.; Sorgente, A.; Lanz, M.; Serido, J.; Vosylis, R.; Fonseca, G.;
et al. How culturally unique are pandemic effects?: Evaluating cultural similarities and differences in effects of age, biological sex,
and political beliefs on COVID Impacts. Front. Psychol. 2022,13, 937211. [CrossRef] [PubMed]
39.
Familiar, I.; Ortiz-Panozo, E.; Hall, B.; Vieitez, I.; Romieu, I.; Lopez-Ridaura, R.; Lajous, M. Factor structure of the Spanish version
of the Patient Health Questionnaire-9 in Mexican women. Int. J. Methods Psychiatr. Res. 2015,24, 74–82. [CrossRef]
40.
Medina-Mora, M.E.; Borges, G.; Benjet, C.; Lara, C.; Berglund, P. Psychiatric disorders in Mexico: Lifetime prevalence in a
nationally representative sample. Br. J. Psychiatry 2007,190, 521–528. [CrossRef]
41.
Cénat, J.M.; Felix, N.; Blais-Rochette, C.; Rousseau, C.; Bukaka, J.; Derivois, D.; Noorishad, P.G.; Birangui, J.P. Prevalence of
mental health problems in populations affected by Ebola virus disease: A systematic review and meta-analysis. Psychiatry Res.
2020,289, 113033. [CrossRef]
42. Maunder, R.G. Was SARS a mental health catastrophe? Gen. Hosp. Psychiatry 2009,31, 316–317. [CrossRef]
43.
González, C.; Ausín, B.; Castellanos, M.Á.; Saiz, J.; López, A.; Ugidos, C.; Muñoz, M. Mental health consequences during the
initial stage of the 2020 Coronavirus pandemic (COVID-19) in Spain. Brain Behav. Immun. 2020,87, 172–176. [CrossRef]
44.
Kishore, J.; Anand, T.; Heena Nazli, T. Depression during COVID-19 Pandemic in India: Findings from an Online Survey. Int. J.
Prev. Curative Community Med. 2020,6, 16–21. [CrossRef]
45.
Kola, L.; Kohrt, B.A.; Hanlon, C.; Naslund, J.A.; Sikander, S.; Balaji, M.; Benjet, C.; Lai, E.Y.; Eaton, J.; Gonsalves, P.; et al.
COVID-19 mental health impact and responses in low-income and middle-income countries: Reimagining global mental health.
Lancet Psychiatry 2021,8, 535–550. [CrossRef] [PubMed]
46.
Bracke, P.; Delaruelle, K.; Dereuddre, R.; Van de Velde, S. Depression in women and men, cumulative disadvantage, and gender
inequality in 29 European countries. Soc. Sci. Med. 2020,267, 113354. [CrossRef] [PubMed]
47.
Alloy, L.B.; Liu, R.T.; Bender, R.E. Stress generation research in depression: A commentary. Int. J. Cogn. Ther.
2010
,3, 380–388.
[CrossRef] [PubMed]
48.
Vigo, D.; Patten, S.; Pajer, K.; Krausz, M.; Taylor, S.; Rush, B.; Raviota, G.; Saxena, S.; Thornicroft, G.; Yatham, L.N. Mental health
of communities during the COVID-19 pandemic. Can. J. Psychiatry 2020,65, 681–987. [CrossRef]
49.
Rutland-Lawes, J.; Wallinheimo, A.S.; Evans, S.L. Risk factors for depression during the COVID-19 pandemic: A longitudinal
study in middle-aged and older adults. BJPsych Open 2021,7, e161. [CrossRef]
Disclaimer/Publisher’s Note:
The statements, opinions and data contained in all publications are solely those of the individual
author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to
people or property resulting from any ideas, methods, instructions or products referred to in the content.
... During the early stages of the pandemic, there was limited investigation into the incipient and unfolding mental health impacts of COVID-19 lockdown policies, particularly on individuals with chronic diseases [23]; however, research on the effects of quarantine during the Middle East Respiratory Syndrome (MERS) outbreak found that these individuals had elevated clinical anxiety and depression levels [24] and increased odds for clinically significant anxiety 4-6 months post quarantine [25]. Since that first year of the pandemic response, multiple studies have shown that individuals with chronic diseases may be an especially vulnerable population for mental health sequelae [26][27][28]. However, more research on the effects of the COVID-19 pandemic on their mental health is needed [26]. ...
Article
Full-text available
Lockdown measures enacted in 2020 to control the spread of COVID-19 led to increases in the prevalence of mental health problems. Due to their high-risk status, individuals with chronic diseases may be at increased risk and disproportionately adversely affected by the COVID-19 pandemic. The investigators examined associations between having a high-risk chronic condition, social connectedness, and general distress and COVID-19-specific distress among U.S. adults during the COVID-19 lockdown. Baseline measures of a longitudinal survey collected at the beginning of the pandemic (April to June 2020) were analyzed to identify factors associated with loss of social connectedness from pre- to post-lockdown. The associations between social connectedness and both general and COVID-19-specific psychological distress were adjusted for certain high-risk chronic illnesses and interaction effects. The sample available for analysis included 1354 subjects (262 high-risk chronic diseases and 1092 without chronic illness). Those reporting the loss of social connectedness were younger (median = 39 vs. 42) and more likely to be unemployed because of the pandemic (19.4% vs. 11.0%). Adjustment for interaction demonstrated a stronger negative association between social connectedness change and the psychosocial impact of COVID-19 for those with high-risk illness(es) (change in connectedness*chronic illness OR = 0.88, 95%CI: 0.79–0.98, p = 0.020). These findings inform our understanding of the distribution and intersection of responses to public health lockdown orders in the U.S. and build further evidence of the importance of social connectedness on psychological distress.
Article
The coronavirus disease 2019 (COVID-19) mortality rate in 55 African countries is almost 4.5 times lower than in the coronavirus disease 2019 (COVID-19) despite Africa having over 4.2 times more people. This mortality paradox is also evident when comparing Nigeria, a heavily populated, poorly vaccinated and weakly mandated country to Israel, a small, highly vaccinated and strictly mandated country. Nigeria has almost 4 times lower COVID mortality than Israel. In this Field of Vision perspective, I explain how this paradox has evolved drawing upon my academic, clinical and social experience. Since April 2020, I’ve developed and been using the Egyptian immune-modulatory Kelleni’s protocol to manage COVID-19 patients including pediatric, geriatric, pregnant, immune-compromised and other individuals suffering from multiple comorbidities. It’s unfortunate that severe acute respiratory syndrome coronavirus 2 is still evolving accompanied by more deaths. However in Africa, we’ve been able to live without anxiety or mandates throughout the pandemic because we trust science and adopted early treatment using safe, and effective repurposed drugs that have saved the majority of COVID-19 patients. This article represents an African and Egyptian tale of honor.
Article
Full-text available
Despite being bio-epidemiological phenomena, the causes and effects of pandemics are culturally influenced in ways that go beyond national boundaries. However, they are often studied in isolated pockets, and this fact makes it difficult to parse the unique influence of specific cultural psychologies. To help fill in this gap, the present study applies existing cultural theories via linear mixed modeling to test the influence of unique cultural factors in a multi-national sample (that moves beyond Western nations) on the effects of age, biological sex, and political beliefs on pandemic outcomes that include adverse financial impacts, adverse resource impacts, adverse psychological impacts, and the health impacts of COVID. Our study spanned 19 nations (participant N = 14,133) and involved translations into 9 languages. Linear mixed models revealed similarities across cultures, with both young persons and women reporting worse outcomes from COVID across the multi-national sample. However, these effects were generally qualified by culture-specific variance, and overall more evidence emerged for effects unique to each culture than effects similar across cultures. Follow-up analyses suggested this cultural variability was consistent with models of pre-existing inequalities and socioecological stressors exacerbating the effects of the pandemic. Collectively, this evidence highlights the importance of developing culturally flexible models for understanding the cross-cultural nature of pandemic psychology beyond typical WEIRD approaches.
Article
Full-text available
Introduction The COVID-19 pandemic has been particularly difficult for populations at risk for mental health problems, such as healthcare professionals and medical students. In the present study, we evaluated the effect of the pandemic on mental health in a sample of Mexican medical students with and without a mental health diagnosis. Method Longitudinal and descriptive study based on scales of suicidal ideation, depressive symptoms and risk of alcohol consumption, conducted in April and December 2020. Results Sample includes 247 medical students, 64.4% are women. Prevalence of depression increased between April and December from 19.84% to 40.08%. In the case of women from 23.67% to 42.60% (χ2 = 0.000) and in men from 11.54% to 34.62% (χ2 = 0.001). In April 16.92% of healthy students presented some sign of depression and in December the percentage increased to 40.80% (χ2 = 0.000). Regarding medicated students, the prevalence in April was 32.61% and in December it was 36.96% (χ2 = 0.662). In April, the medicated students with risk of suicidal ideation were 17 out of 46 (36.96%), compared to the students without a diagnosis of psychiatric illness were 29 out of 201 (13.43%) (χ2 = 0.000). For December, the non-medicated students at risk of suicidal ideation were 34 out of 201 (16.91%), and the medicated students were 12 out of 46 (26.09%) (χ2 = 0.149). Conclusions The pandemic has increase the rate of depression in medical students, being more severe in women. Students under psychiatric treatment showed a higher prevalence of depression; however, the fact of being under treatment resulted in a protective factor for the increase in the prevalence of depression. It is important to deepen the understanding of the causes of depression and to disseminate among the university community the benefits of early detection and treatment of people with socio-emotional disorders.
Article
Full-text available
Since stress is known to play a role in the development of physical and mental illness, empirically validated measurements are required to assess the effect of adverse events such as the COVID-19 pandemic. The purpose of this study was to develop and evaluate the psychometric properties of the Adversity and Stress Scale (ASS). A sample of 3937 adults living in Mexico was used. The structure of the instrument was evaluated using exploratory factor analysis (EFA) and confirmatory factor analysis (CFA). Construct validity was measured through associations between the ASS and psychological symptoms. In the EFA, the relational and contextual dimensions of stress were identified. A good fit was obtained in the CFA (CFI = 0.980, RMSEA = 0.040). The ASS score was associated with all the selected variables in the expected direction, and internal consistency was α = .86. The ASS is a valid, reliable measure, with the potential to be used in other adverse events.
Article
Full-text available
Background Before 2020, mental disorders were leading causes of the global health-related burden, with depressive and anxiety disorders being leading contributors to this burden. The emergence of the COVID-19 pandemic has created an environment where many determinants of poor mental health are exacerbated. The need for up-to-date information on the mental health impacts of COVID-19 in a way that informs health system responses is imperative. In this study, we aimed to quantify the impact of the COVID-19 pandemic on the prevalence and burden of major depressive disorder and anxiety disorders globally in 2020. Methods We conducted a systematic review of data reporting the prevalence of major depressive disorder and anxiety disorders during the COVID-19 pandemic and published between Jan 1, 2020, and Jan 29, 2021. We searched PubMed, Google Scholar, preprint servers, grey literature sources, and consulted experts. Eligible studies reported prevalence of depressive or anxiety disorders that were representative of the general population during the COVID-19 pandemic and had a pre-pandemic baseline. We used the assembled data in a meta-regression to estimate change in the prevalence of major depressive disorder and anxiety disorders between pre-pandemic and mid-pandemic (using periods as defined by each study) via COVID-19 impact indicators (human mobility, daily SARS-CoV-2 infection rate, and daily excess mortality rate). We then used this model to estimate the change from pre-pandemic prevalence (estimated using Disease Modelling Meta-Regression version 2.1 [known as DisMod-MR 2.1]) by age, sex, and location. We used final prevalence estimates and disability weights to estimate years lived with disability and disability-adjusted life-years (DALYs) for major depressive disorder and anxiety disorders. Findings We identified 5683 unique data sources, of which 48 met inclusion criteria (46 studies met criteria for major depressive disorder and 27 for anxiety disorders). Two COVID-19 impact indicators, specifically daily SARS-CoV-2 infection rates and reductions in human mobility, were associated with increased prevalence of major depressive disorder (regression coefficient [B] 0·9 [95% uncertainty interval 0·1 to 1·8; p=0·029] for human mobility, 18·1 [7·9 to 28·3; p=0·0005] for daily SARS-CoV-2 infection) and anxiety disorders (0·9 [0·1 to 1·7; p=0·022] and 13·8 [10·7 to 17·0; p<0·0001]. Females were affected more by the pandemic than males (B 0·1 [0·1 to 0·2; p=0·0001] for major depressive disorder, 0·1 [0·1 to 0·2; p=0·0001] for anxiety disorders) and younger age groups were more affected than older age groups (−0·007 [–0·009 to −0·006; p=0·0001] for major depressive disorder, −0·003 [–0·005 to −0·002; p=0·0001] for anxiety disorders). We estimated that the locations hit hardest by the pandemic in 2020, as measured with decreased human mobility and daily SARS-CoV-2 infection rate, had the greatest increases in prevalence of major depressive disorder and anxiety disorders. We estimated an additional 53·2 million (44·8 to 62·9) cases of major depressive disorder globally (an increase of 27·6% [25·1 to 30·3]) due to the COVID-19 pandemic, such that the total prevalence was 3152·9 cases (2722·5 to 3654·5) per 100 000 population. We also estimated an additional 76·2 million (64·3 to 90·6) cases of anxiety disorders globally (an increase of 25·6% [23·2 to 28·0]), such that the total prevalence was 4802·4 cases (4108·2 to 5588·6) per 100 000 population. Altogether, major depressive disorder caused 49·4 million (33·6 to 68·7) DALYs and anxiety disorders caused 44·5 million (30·2 to 62·5) DALYs globally in 2020. Interpretation This pandemic has created an increased urgency to strengthen mental health systems in most countries. Mitigation strategies could incorporate ways to promote mental wellbeing and target determinants of poor mental health and interventions to treat those with a mental disorder. Taking no action to address the burden of major depressive disorder and anxiety disorders should not be an option. Funding Queensland Health, National Health and Medical Research Council, and the Bill and Melinda Gates Foundation.
Article
Full-text available
People can increase their use of psychoactive substances in response to stressful situations as a maladaptive mechanism for reducing negative affective states. It is therefore necessary to examine changes in the use of such substances and their relationship to mental health in light of the COVID-19 pandemic. Objective: Evaluate the relationship between psychoactive substances and stress, emotional state, and symptomatology during the COVID-19 lockdown in Mexico. Method: A national survey was conducted, using the free Google Forms platform, of residents of Mexico aged 18 and older. The survey was disseminated through social media. Results: The sample comprised 4,122 individuals, mostly women (71.8%), with an age range of 18–81 years (M = 37.08, SD = 12.689), of which 46.8% were single, and 42.9% married. In general, there was a reduction in substance use during the first 2 months of the quarantine; the most commonly used substances were alcohol, tobacco, and tranquilizers. Respondents who described having greater use than before the pandemic presented greater stress, depressive symptomatology, and perceived threat than those who did not use substances. Conclusions: Respondents who did not use substances reported lower levels of stress, depressive symptomatology, impact of the coronavirus pandemic, and perception of its threat. Women reported greater stress, depressive symptomatology, and emotional intensity than men.
Article
Full-text available
Background The COVID-19 pandemic and resultant social restrictions have had widespread psychological ramifications, including a rise in depression prevalence. However, longitudinal studies on sociodemographic risk factors are lacking. Aims To quantify longitudinal changes in depression symptoms during the pandemic compared with a pre-pandemic baseline, in middle-aged and older adults, and identify the risk factors contributing to this. Method A total of 5331 participants aged ≥50 years were drawn from the English Longitudinal Study of Ageing. Self-reported depression symptoms in June/July 2020 were compared with baseline data from 2–3 years prior. Regression models investigated sociodemographic and lifestyle variables that could explain variance in change in depression. Results Within-participant depression scores increased significantly from pre-pandemic levels: 14% met the criteria for clinical depression at baseline, compared with 26% during the pandemic. Younger age, female gender, higher depression scores at baseline, living alone and having a long-standing illness were significant risk factors. Gender-stratified regression models indicated that older age was protective for women only, whereas urban living increased risk among women only. Being an alcohol consumer was a protective factor among men only. Conclusions Depression in UK adults aged ≥50 years increased significantly during the pandemic. Being female, living alone and having a long-standing illness were prominent risk factors. Younger women living in urban areas were at particularly high risk, suggesting such individuals should be prioritised for support. Findings are also informative for future risk stratification and intervention strategies, particularly if social restrictions are reimposed as the COVID-19 crisis continues to unfold.
Article
Full-text available
Introduction The COVID-19 outbreak has involved a permanent and significant increase of fear and worries related to the virus and the measures taken to avoid contagion, such as confinement. Objective To explore the relationship between emotional responses and coping strategies used to face the first confinement among the Mexican adult population and inquire about differences by sex. Method An exploratory study was conducted through a self-administered online survey. It included questions about sociodemographic characteristics, emotions about pandemic information, and coping strategies. An informed consent form was presented prior to data collection. Chi square and Kruskal-Wallis were performed for bivariate analyses. Results A total of 2,650 participants completed the survey (21.6% were men). Significantly more men than women reported feeling calm (p < .001), hopeful (p = .011), and indifferent (p = .002). In contrast, more women, compared to men significantly reported feeling worried (p < .001), fearful (p < 0.001), and sad (p < .001). More women reported being emotionally close to other people (p = .027), seeking help from friends and family to share emotions and concerns (p < .001), and they frequently prayed as a coping strategy regardless of their emotions (p = .005). Discussion and conclusion While women are the least affected by the contagion and their symptoms are milder than in men, they present the most negative emotions, particularly of worry, but they also used more caring and helpful behaviors in comparison with men. These results can serve as a basis for developing research with a gender perspective that delves into the differences by sex found in this study.
Article
Social distancing has limited the spread of the coronavirus (COVID-19), but also changed communication patterns. However, studies of how mental health in older adults relates to the usage of different modes of interpersonal communication are sparse. The aim of this study was to analyze how COVID-19-related changes in the frequencies of using different modes of communication (digital or in-person) have influenced mental health in older adults from 27 countries. Our study was based on part of Wave 8 of the SHARE data set, which focused on the living situation of older adults during the pandemic. Findings suggest that in-person communication benefited mental health in people aged ≥60 years more than digital communication. The older the person, the less beneficial digital communication was for their mental health, especially during interactions with their children. Our findings are useful for researchers and practitioners interested in technologically meditated interventions.
Article
Most of the global population live in low-income and middle-income countries (LMICs), which have historically received a small fraction of global resources for mental health. The COVID-19 pandemic has spread rapidly in many of these countries. This Review examines the mental health implications of the COVID-19 pandemic in LMICs in four parts. First, we review the emerging literature on the impact of the pandemic on mental health, which shows high rates of psychological distress and early warning signs of an increase in mental health disorders. Second, we assess the responses in different countries, noting the swift and diverse responses to address mental health in some countries, particularly through the development of national COVID-19 response plans for mental health services, implementation of WHO guidance, and deployment of digital platforms, signifying a welcome recognition of the salience of mental health. Third, we consider the opportunity that the pandemic presents to reimagine global mental health, especially through shifting the balance of power from high-income countries to LMICs and from narrow biomedical approaches to community-oriented psychosocial perspectives, in setting priorities for interventions and research. Finally, we present a vision for the concept of building back better the mental health systems in LMICs with a focus on key strategies; notably, fully integrating mental health in plans for universal health coverage, enhancing access to psychosocial interventions through task sharing, leveraging digital technologies for various mental health tasks, eliminating coercion in mental health care, and addressing the needs of neglected populations, such as children and people with substance use disorders. Our recommendations are relevant for the mental health of populations and functioning of health systems in not only LMICs but also high-income countries impacted by the COVID-19 pandemic, with wide disparities in quality of and access to mental health care.
Book
This volume constitutes the proceedings of the 12th International Conference on Social Informatics, SocInfo 2020, held in Pisa, Italy, in October 2020. The 30 full and 3 short papers presented in these proceedings were carefully reviewed and selected from 99 submissions. The papers presented in this volume cover a broad range of topics, ranging from works that ground information-system design on social concepts, to papers that analyze complex social systems using computational methods, or explore socio-technical systems using social sciences methods.